Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia

  1. Home
  2. Research Articles
Journal Title: 
Haematologica
Primary Author: 
Connor MP
Author(s): 
Connor MP, Prathapa N, Frey NV, Gill SI, Hexner EO, Bruno XJ, Lai CE, Loren AW, Luger SM, Matthews AH, McCurdy SR, Perl AE, Porter DL, Zeringue A, Oved JH, Olson TS, Pratz KW, Babushok DV
Original Publication Date: 
Thursday, April 18, 2024
Full Article on PubMed: 
https://www.ncbi.nlm.nih.gov/pubmed/38634143/
Bone Marrow Disease(s):